The US Centers for Medicare and Medicaid Services lacks the statutory authority to require manufacturers to disclose prescription drug prices in direct-to-consumer TV ads and is precluded from doing so by the First Amendment, manufacturers, free speech advocates and advertisers argue in recent comments to CMS.
The comments respond to a proposed rule on the price disclosure requirement released by CMS in mid-October. They detail anticipated legal and other arguments against the proposal. (Also see "